Description
CJC‑1295 without DAC (Mod GRF 1‑29) is a synthetic analog of Growth Hormone-Releasing Hormone engineered for controlled, short-duration growth hormone (GH) stimulation in laboratory research. Unlike its DAC-modified counterpart, this variant lacks the Drug Affinity Complex, resulting in a shorter half-life (≈30 min) and enabling pulsatile GH receptor activation
Researchers favor this peptide for studies requiring precise temporal control of GH signaling—ideal for in-vitro assays, acute cellular response, and metabolic pathway investigations. Due to its rapid clearance, it’s well-suited for protocols demanding frequent dosing or rapid washout phases
Key Research Applications:
- Short-term GH pulse modeling
- In-vitro tissue culture protocols
- Receptor dynamics and signaling studies
- Metabolic and gene expression analysis
Product Highlights:
- 5 mg lyophilized peptide (no DAC)
- Purity ≥ 95% from batch-tested synthesis
- Designed for precise dosing and replicability
